Dr. Moore’s research focus is on cancer genomics and technology development, with a personal interest in cancer-causing infectious agents. One highlight being the Fusobacterium and colo-rectal cancer association (Castellarin et. al. Genome Research 2012) that was named one of the 10 medical breakthroughs of 2012 by Time magazine.

Dr. Moore is fortunate to have been involved in a large number of research projects whilst at the GSC, contributing to impactful publications. He was listed by Clarivate as a “highly cited researcher of 2018” by virtue of being in the top 1% of cited scientists. He is an author on over 170 articles, each with more than 10 citations.